Antibiotic use and risk of ischemic stroke in the elderly

被引:12
作者
Luchsinger, JA
Pablos-Mendez, A
Knirsch, C
Rabinowitz, D
Shea, S
机构
[1] Columbia Univ Coll Phys & Surg, Div Gen Med, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Div Infect Dis, New York, NY 10032 USA
[3] Columbia Univ, Joseph P Mailman Sch Publ Hlth, Div Epidemiol, New York, NY USA
[4] Pfizer Pharmaceut Inc, New York, NY USA
[5] Columbia Univ, Dept Stat, New York, NY USA
关键词
D O I
10.1016/S0002-9343(01)00871-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: To determine whether treating infections with antibiotics that have antichlamydial activity decreases the risk of ischemic stroke in the elderly. SUBJECTS AND METHODS: We analyzed data from 199 553 subjects 65 years and older in a health care claims database who had continuous health and pharmacy coverage for at least 2 years between January 1, 199 1, and September 30, 1997. Using proportional hazards models with time-dependent covariates for prior antibiotic prescription and adjusting for cardiovascular risk factors, we determined the associations between antibiotic use and first claim for ischemic stroke (n = 7,335) during the observation period. RESULTS: Rates of stroke (per 1,000 person-years) were 6.64 for macrolides, 9.27 for quinolones, 7.49 for tetracyclines, 6.88 for penicillins, 7.97 for cephalosporins, 8.58 for trimethroprim-sulfamethoxazole, and 7.29 for subjects with no antibiotic claims. The adjusted hazard ratios (HR) were 0.94 (95% confidence interval [CI]: 0.87 to 1.01) for macrolides, 1.04 (95% CI: 0.91 to 1.18) for tetracyclines, 1.02 (95% Cl: 0.95 to 1.08) for penicillins, and 1.00 (95% Cl: 0.82 to 1.22) for trimethroprim-sulfamethoxazole. Subjects with claims for quinolone antibiotics (HR = 1.17; 95% Cl: 1.09 to 1.26) and cephalosporins (HR = 1.09; 95% Cl: 1.02 to 1.16) had a slightly higher risk of stroke. CONCLUSION: Exposures to short courses of antibiotics are not associated with lower risk of ischemic stroke in patients aged 65 years and older. (C) 2001 by Excerpta Medica, Inc.
引用
收藏
页码:361 / 366
页数:6
相关论文
共 54 条
[1]  
*AM HEART ASS, 1997, HEART STROK FACTS 19
[2]   Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection -: The azithromycin in coronary artery disease:: Elimination of myocardial infection with Chlamydia (ACADEMIC) study [J].
Anderson, JL ;
Muhlestein, JB ;
Carlquist, J ;
Allen, A ;
Trehan, S ;
Nielson, C ;
Hall, S ;
Brady, J ;
Egger, M ;
Horne, B ;
Lim, T .
CIRCULATION, 1999, 99 (12) :1540-1547
[3]  
[Anonymous], STAT METHODS EPIDEMI
[4]   EVIDENCE FOR A MONOCLONAL ORIGIN OF HUMAN ATHEROSCLEROTIC PLAQUES [J].
BENDITT, EP ;
BENDITT, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (06) :1753-1756
[5]   Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease [J].
Benesch, C ;
Witter, DM ;
Wilder, AL ;
Duncan, PW ;
Samsa, GP ;
Matchar, DB .
NEUROLOGY, 1997, 49 (03) :660-664
[6]   Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice [J].
Bin, XX ;
Wolf, K ;
Schaffner, T ;
Malinverni, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1761-1764
[7]  
BRUGGEMAN CA, 1988, THROMB HAEMOSTASIS, V59, P264
[8]   Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia - The West Birmingham Stroke Project [J].
Cook, PJ ;
Honeybourne, D ;
Lip, GYH ;
Beevers, DG ;
Wise, R ;
Davies, P .
STROKE, 1998, 29 (02) :404-410
[10]   Chlamydia pneumoniae and the risk of first ischemic stroke -: The Northern Manhattan Stroke Study [J].
Elkind, MSV ;
Lin, IF ;
Grayston, JT ;
Sacco, RL .
STROKE, 2000, 31 (07) :1521-1525